Path ID: DB01122_MESH_D009157_1
Concepts
| Identifier | Name | Type |
|---|---|---|
| MESH:D000549 | ambenonium | Drug |
| UniProt:P22303 | Acetylcholinesterase | Protein |
| GO:0001507 | acetylcholine catabolic process in synaptic cleft | BiologicalProcess |
| HP:0001324 | Muscle weakness | PhenotypicFeature |
| MESH:D009157 | Myasthenia Gravis | Disease |
Relationships
NOTE: predicates are annotated in Biolink Model (v1.3.0)
| Subject | Predicate | Object |
|---|---|---|
| Ambenonium | DECREASES ACTIVITY OF | Acetylcholinesterase |
| Acetylcholinesterase | POSITIVELY REGULATES | Acetylcholine Catabolic Process In Synaptic Cleft |
| Acetylcholine Catabolic Process In Synaptic Cleft | CONTRIBUTES TO | Muscle Weakness |
| Muscle Weakness | MANIFESTATION OF | Myasthenia Gravis |
Reference: